Literature DB >> 9042858

Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis.

A N Gerber1, T R Klesert, D A Bergstrom, S J Tapscott.   

Abstract

Genetic studies have demonstrated that MyoD and Myf5 establish the skeletal muscle lineage, whereas myogenin mediates terminal differentiation, yet the molecular basis for this distinction is not understood. We show that MyoD can remodel chromatin at binding sites in muscle gene enhancers and activate transcription at previously silent loci. TGF-beta, basic-FGF, and sodium butyrate blocked MyoD-mediated chromatin reorganization and the initiation of transcription. In contrast, TGF-beta and sodium butyrate did not block transcription when added after chromatin remodeling had occurred. MyoD and Myf-5 were 10-fold more efficient than myogenin at activating genes in regions of transcriptionally silent chromatin. Deletion mutagenesis of the MyoD protein demonstrated that the ability to activate endogenous genes depended on two regions: a region rich in cysteine and histidine residues between the acidic activation domain and the bHLH domain, and a second region in the carboxyl terminus of the protein. Neither region has been shown previously to regulate gene transcription and both have domains that are conserved in the Myf5 protein. Our results establish a mechanism for chromatin modeling in the skeletal muscle lineage and define domains of MyoD, independent of the activation domain, that participate in chromatin reorganization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042858     DOI: 10.1101/gad.11.4.436

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  106 in total

1.  Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family.

Authors:  D A Bergstrom; S J Tapscott
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  EMBO Workshop Report: Molecular genetics of muscle development and neuromuscular diseases Kloster Irsee, Germany, September 26-October 1, 1999.

Authors:  T Brand; G Butler-Browne; E M Füchtbauer; R Renkawitz-Pohl; B Brand-Saberi
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

Review 3.  Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms.

Authors:  M E Massari; C Murre
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  Prolonged passive stretch of rat soleus muscle provokes an increase in the mRNA levels of the muscle regulatory factors distributed along the entire length of the fibers.

Authors:  E Zádor; L Dux; F Wuytack
Journal:  J Muscle Res Cell Motil       Date:  1999-05       Impact factor: 2.698

Review 5.  Molecular regulation of cytokine gene expression during the immune response.

Authors:  J P Viola; A Rao
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

6.  cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.

Authors:  M Kitzmann; M Vandromme; V Schaeffer; G Carnac; J C Labbé; N Lamb; A Fernandez
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 7.  Epigenetic regulation of skeletal myogenesis.

Authors:  Valentina Saccone; Pier Lorenzo Puri
Journal:  Organogenesis       Date:  2010 Jan-Mar       Impact factor: 2.500

Review 8.  Regulation of cellular chromatin state: insights from quiescence and differentiation.

Authors:  Surabhi Srivastava; Rakesh K Mishra; Jyotsna Dhawan
Journal:  Organogenesis       Date:  2010 Jan-Mar       Impact factor: 2.500

Review 9.  Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.

Authors:  Erin E Talbert; Denis C Guttridge
Journal:  Semin Cell Dev Biol       Date:  2015-09-16       Impact factor: 7.727

10.  Identification of novel MyoD gene targets in proliferating myogenic stem cells.

Authors:  Jeffrey C Wyzykowski; Therry I Winata; Natalia Mitin; Elizabeth J Taparowsky; Stephen F Konieczny
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.